Dr. Reddy's Laboratories Overview

  • Founded
  • 1984
Founded
  • Status
  • Public
  • Employees
  • 22,739
Employees
  • Stock Symbol
  • 500124
Stock Symbol
  • Investments
  • 27
  • Share Price
  • $53.18
  • (As of Thursday Closing)

Dr. Reddy's Laboratories General Information

Description

Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets.

Contact Information

Website
www.drreddys.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
  • 8-2-337, Road Number Three
  • Banjara Hills
  • Hyderabad, Telangana 500034
  • India
+91 040 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dr. Reddy's Laboratories Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$53.18 $51.70 $48.01 - $75.29 $8.58B 166M 16K $2.30

Dr. Reddy's Laboratories Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 11,016,463 10,264,837 6,803,220 6,890,137
Revenue 2,803,764 2,550,030 2,457,408 2,198,105
EBITDA 625,896 504,786 430,666 496,510
Net Income 355,929 231,694 274,425 268,529
Total Assets 3,795,412 3,614,788 3,079,302 3,245,923
Total Debt 378,387 412,658 293,052 552,648
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Dr. Reddy's Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dr. Reddy's Laboratories‘s full profile, request access.

Request a free trial

Dr. Reddy's Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across t
Pharmaceuticals
Hyderabad, India
22,739 As of 2021
00000
00000000000 00000

00000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000 000000000
Mumbai, India
00000 As of 0000
00000000

0000 000

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
000000000000000
Petach Tikva, Israel
00000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dr. Reddy's Laboratories Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India 00000 00000000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
00000 Corporation 00000 000000000
00000000 0000 0000 Corporation Noida, India 00 00000 00000000000 00000
00000 000000 Corporation Ahmedabad, India 00000 00000000
You’re viewing 5 of 26 competitors. Get the full list »

Dr. Reddy's Laboratories Patents

  • 1,616

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 58

    Granted

  • 20

    Pending

  • 000

    Expiring in next 12 mo

Dr. Reddy's Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210340156-A1 Process for preparation of eribulin and intermediates thereof Pending 09-Oct-2018 0000000000
EP-3864011-A1 Process for preparation of eribulin and intermediates thereof Pending 09-Oct-2018 0000000000
CA-3107702-A1 Topical oleaginous compositions Pending 16-Aug-2018 0000000000
AU-2019322315-A1 Topical oleaginous compositions Pending 16-Aug-2018 0000000000
US-20200054654-A1 Topical oleaginous compositions Pending 16-Aug-2018 A61K9/06
To view Dr. Reddy's Laboratories’s complete patent history, request access »

Dr. Reddy's Laboratories Executive Team (27)

Name Title Board Seat Contact Info
Erez Israeli Chief Executive Officer
M. Ramana Chief Executive Officer, Branded Markets (India and Emerging Markets)
Patrick Aghanian Chief Executive Officer, European Generics
Marc Kikuchi Chief Executive Officer, North America Generics
Parag Agarwal Chief Financial Officer, Finance
You’re viewing 5 of 27 executive team members. Get the full list »

Dr. Reddy's Laboratories Board Members (21)

Name Representing Role Since
00000 0000000 Self Board Member 000 0000
000000 0000 Self Board Member 000 0000
00000 000000 00.0 Self Board Member 000 0000
0.0. 000000 Dr. Reddy's Laboratories Co-Chairman of the Board & Managing Director 000 0000
0. 00000 Dr. Reddy's Laboratories Board Member & Chairman 000 0000
You’re viewing 5 of 21 board members. Get the full list »

Dr. Reddy's Laboratories Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dr. Reddy's Laboratories Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dr. Reddy's Laboratories‘s full profile, request access.

Request a free trial

Dr. Reddy's Laboratories Investments & Acquisitions (27)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 24-Feb-2022 0000000000 Distributors (Healthcare) 0000000 0
00000000 0000 28-Nov-2020 000000000 000.00 Buildings and Property 0. 000000
000000000 (00 10-Jun-2020 0000000000 00000 Pharmaceuticals 0.0. 0000
000000000 (00 10-Jun-2020 0000000000 00000 Pharmaceuticals 0.0. 0000
Wockhardt (Generics Business Divisions) 10-Jun-2020 Merger/Acquisition 00000 Pharmaceuticals 0.0. 0000
You’re viewing 5 of 27 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Dr. Reddy's Laboratories Subsidiaries (8)

Company Name Industry Location Founded
Nimbus Health Distributors (Healthcare) Offenbach, Germany 2018
00000000 000000 Drug Delivery South Brunswick Township, NJ 0000
00000000 Biotechnology Bangalore, India 0000
000000000000 00000 Pharmaceuticals Azpeitia, Spain 0000
000000000 Distributors/Wholesale Augsburg, Germany 0000
You’re viewing 5 of 8 subsidiaries. Get the full list »